The treatments all improved the limb motor function ( group A : 26.00 ( 22 ) vs 37.00 ( 33 ) ; group B : 30.50 ( 21 ) vs 39.50 ( 36 ) ) , the independent activity of life , ADL ( group A : 43.50 + / - 22.25 vs 57.50 + / - 22.25 ; group B : 52.83 + / - 16.59 vs 66.67 + / - 12.82 ) and the quality of life ( group A : 122.23 + / - 30.00 vs 145.50 + / - 28.14 ; group B : 132.43 + / - 23.87 vs 151.47 + / - 22.37 ) in the patients of the two groups .